Cambridge Investment Research Advisors, Inc. Charles River Laboratories International, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,926 shares of CRL stock, worth $344,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,926
Previous 1,803
6.82%
Holding current value
$344,734
Previous $333,000
12.91%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CRL
# of Institutions
625Shares Held
55MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$911 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$767 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$428 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$410 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...